Paclitaxel Plus Radiation With Erlotinib to Treat Esophageal Squamous Carcinoma
Status:
Unknown status
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety and effectiveness of erlotinib and
chemoradiotherapy in patients with unresectable esophageal or gastro-esophageal squamous
cancer .
Phase:
Phase 3
Details
Lead Sponsor:
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences